1620 Investment Advisors’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18K Hold
1,590
0.01% 406
2025
Q1
$18.3K Hold
1,590
0.01% 390
2024
Q4
$13.5K Hold
1,590
0.01% 427
2024
Q3
$18.4K Hold
1,590
0.01% 410
2024
Q2
$18.7K Buy
+1,590
New +$18.7K 0.01% 400